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The patient with heart disease and the physician pro-
viding cardiovascular health care have experienced dra-
matic change since the American College of Cardiology
first published its journal 25 years ago. During the dec-
ade before 1958, cardiology and cardiovascular surgery
emerged as specialties. Surgery by closed techniques
flourished and open heart surgery began. Since 1958,
spectacular progress has occurred. Closed chest massage
and defibrillation, electronic monitoring, advances in
electrophysiology and a new pharmacology have changed
cardiology. The coronary care unit has evolved into a
comprehensive coronary care system. Pacemakers, myo-
The patient with heart disease and the physician live in a
different world from that of 25 years ago when the American
College of Cardiology introduced its official journal. The
College now begins its second quarter century of publication.
The year 1958 was a watershed in the history of car-
diology. It had been a little more than a decade since the
end of World War II. During that interim, cardiology had
become a specialty in its own right. Department s of car-
diovascular surgery emerged . There was unparalleled ex-
pansion in training and research in cardiovascular medicine
and surgery, financed and stimulated largely by the new
National Heart Institute. It was a period of ferment and
change. The prospect of prodigious progre ss lay ahead.
One way to comprehend the change experienced by both
patient and physician during this quarter century is to browse
through Volume I of 1958 and then through Volume 49
which began the 25th year of publication by the American
College of Cardiology. The number of article s has tripled.
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cardial revascularization and open heart surgery have
become commonplace and percutaneous angioplasty an
option. As custodians of cardiology's historic advances,
the cardiologist and cardiovascular surgeon are cast in
a role of decision maker and problem solver. Today's
diagnostic and therapeutic cardiology, used appropri-
ately, has great potential for good-used inappro-
priately, for great harm. The patient has the right to
expect the physician to act objectively and appropriately
in dealing with problems that may threaten his or her
livelihood or life. The physician who does less is an un-
worthy heir to cardiology's great legacy of 1983.
There is a striking increase in papers devoted to basic.
applied and clinical research . Moving quickly from Volume
1 to Volume 49 create s a kind of Rip Van Winkle effect.
It is as if the reader has awakened in a world where every-
thing is strange and new .
Cardiology in 1958
In 1958, closed chest cardiac massage to maintain the cir-
culation and external defibrillation to restore the heartbeat
were not yet in clinical use (1-4) . While catheterization of
the right and left chambers of the heart was well known,
techniques were primitive compared with those of today
(5,6). Tran sseptal catheterization of the left heart chambers,
now used rarely, had not been introduc ed (7). Contrast
angiography and ventriculography had very limited clinical
application. Coronary arteriography had not yet demon-
strated the feasibilit y of myocardial revascularization by
internal mammary artery implantation into the left ventricl e
(8,9). When the College journal first went to press, car-
diologists had not yet recognized the vast clinical impl i-
cation s of visualizing coronary circulation and the potent ial
for surgical revascularization. Intracardiac pacemaking and
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permanent tran svenous pacemakers, commonplace toda y.
were not in use (10). Indeed. external pacemakers were
relatively new and not yet cast aside ( I I ).
Cardiac surgery. The year 1958 marked perhaps the
zenith of progress in the closed surgical treatment of con-
genital and acquired valvular heart disease (12). The pre-
vious decade had seen surgical relief of stenotic mitral.
aortic and pulmonary valves as well as some success ful
recon stru ctive efforts (13-16). Congenital lesions. such as
atrial and ventricular septal defects. were yielding to the
surgeon's hand (17). Open heart surgery was done by hy-
pothermia ( 18). The pump oxygenator and open heart tech-
niques were coming into vogue ( 19 .20) . Some 40 articles
on the subject were publi shed in the English language in
1957. Titles still appeared in 1958 on internal mammary
artery ligation (21). implantation of the internal mammary
artery into the left ventricle and poudrage to treat coronary
artery disease (22. 23 ).
Diagnostic tests. Balli stocardiography was popular in
the literature of 1958 and the subject of seve ral sympos ia
in the College journal. High technology meant electroky-
mography and intracardiac phonocard iography. The only
mention of radio isotopes in the College jo urnal of 1958
described treatment of angina pectoris with radioactive io-
dine to produce a hypothyroid state (24) . How could the
physician of 1958 anticipate that 25 years later , Volume 49
would print a spectrum of articles on imaging the myocar-
dium to define anatomy and function using radionu clides?
Pharmacologic therapy. Compared with today. the
pharmacology of 1958 was limited in scope and effective-
ness. Mercurials were the leading diuretics. The thiaz ides,
furosem ide and ethacrynic acid were still in the clinical
future (25.26). There were , indeed. many article s on the
treatment of hypertension . They reported such agent s as
rauwolfia, cryptenamine and protoveratrine . Beta-receptor
blocking agent s. calcium antagonists and angiotensin-con-
verting enzyme inhibitors were unknown . ln a single sup-
plement to the College journ al of [9 82. there were more
article s on dru g treatment than in the entire first volume of
1958.
Although the electrocardiographic diagnosis of arrh yth-
mias was sophisticated in 1958. electrophysiologic studies
since then have enhanced our understanding of mechani sms
(27). The phy sician of today is startled to see intravenous
quinidine advocated in the management of ventricular tachy-
cardia (28) . Therapeutic choices were limited . Procainamide
was a relatively recent alternative . A quarter of a centu ry
later. if the ga laxy of ant iarrh ythmic agent s. including li-
docaine. beta-receptor blockin g agent s and ca lcium antag-
onists failed . the cardiologist could resort to sophisticated
electrophys iolog ic mapping and surgery (29. 30) .
Stress testing and diagnosis of coronary artery dis-
ease. In 1958, the Master two- step test (31) was the stan-
dard provo cative exercise test to diagnose ischemic coron ary
artery disease. Today. the Master test has been replaced by
the multilevel bicycle ergometer and treadm ill. The decline
of the Master test was dramati cally illustrated at a recent
presentation to a group of our fourth year medical students
and junior house officers. The vast majority had never heard
of the Ma ster test. Whil e stress in relation to coronary dis-
ease was discussed in 1958 (32), the term type A behavior
pattern to describe the coronary-prone personality had not
yet becom e a part of the common language (33) . Since that
time. interest in stress and the genesis and management of
coronary disease has continued to increase (34). The entire
field of myocardial imaging is new since 1958. Echocar-
diograph y and radionuclides have revolutionized the non-
invasive approach to valvul ar. myocardial and indirectly to
coronary heart disease (35,36).
Progress in Cardiology Since 1958
Although its literature did not anticipate many subsequent
spectacular advances . cardiology in 1958 was poised for
progress. By 1960, the surgical treatment of angina pectori s
was already being assessed (37). In that same year. there
was a report of segmental perfusion of coronary arter ies
with fibrinolysin in acute myocardial infarction (38). A spe-
cial unit was proposed for the treatment of patients undergo-
ing open cardiotomy (39). Surgical appro aches to diseases
of the great vessels became well establi shed (40). Progress
began to accelerate exponenti ally .
The Coronary Care Unit
After World War II. there was a great proliferation of elec-
tronic equ ipment. The ability to mon itor the electrocardio-
gram introduced an entirely new dimen sion to the under-
standing of acute coronary heart disease . Closed cardi ac
massage and external defibrillation heralded a new era of
cardiac resuscitation. Thi s triad of monitoring. external de-
fibrillati on and closed che st massage made possible the cor-
ona ry care unit which was introdu ced in 1962 (4 1-43) . The
coronary care unit was a major development of the past 25
years . Its impact on cardi ology was monumental. From a
mode st beginning in a community hospital. the coron ary
care unit proved that progress and innovation were not en-
tirely the province of the great centers . The recognit ion and
treatment of cardiac arrhythmias changed from a somewhat
esoteric pursuit to a practical requirement for every physi-
cian and nurse who treated patients with acute coronary
disease .
The coronary care unit Triggered 0 virtual revolution ,
not limited 10 coronary disease . The nursing pro fession
rapidly ass umed a major role in the care of the acute ly ill
patient. The respon sib ility of the nurse . and consequently
nursing educational requirements. changed dramatically. The
effectiveness of the coronary care concept was not lost on
those intere sted in other areas of acute care. Medical and
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surgical inten sive care units . pulmonary care units . burn
units and many others were develop ed . Succe ss in the cor-
onary care unit was realized from the control of arrhythmias.
which cau sed many deaths early in the course of acute
myocardial infarction. Recogniti on and treatment of life-
threatenin g arrhythmias with lidocaine and prompt defi-
brillation and cardioversion reduced postmyocardial infarc-
tion arrhythmic deaths to a minimum .
The problem oflate postcoronary care unit mortality was
challenged by the intermediate coronary care unit (44.45 ).
Surveill ance was continued throughout the later phases of
the postmyocardial infarction hospital stay. These units are
still in use today. although their life-saving value has not
been established with certainty (46).
Interest then turned to the point ofentry into the coronary
care system . Vast public educational programs created a
popul ation able to recognize the signs and symptoms of
acute coronary heart disease and to ass ist in life support and
resuscitation before arrival of professional help. Ambu-
lances evolved into mobile coronary care units staffed by
well tra ined paramedics. Electrocard iographic monitoring
and a coronary care unit approach began in the hospital
emergency room immediately on arrival of the patient with
chest pain.
Bedside hemodynamic monitoring and therapy. The
coronary care unit did not stand long on the laurels it achieved
through the control of arrh ythmias. In the early 1970s. the
Swan-Ganz catheter made possible bedside hemodynami c
appraisal (47) . A new approach to diagnosis and treatment
of acute myocardial infarction followed . It was the era of
hemodynami c monitoring and management. Such terms as
preload and afterioad introduced a new language to coron ary
care . As often happens. effective therapy followed accurate
diagnosis . Hemodynamic monit oring and a new pharma-
cology of potent diuretic drugs. vasodil ators, beta-receptor
blocking drugs, pressor agents and calcium antagonists helped
to transform the coronary care unit into a physiologic lab-
oratory. Concurrently, surgery became bolder and more suc-
cess ful (48) . Complicat ions of acute myocardial infarction .
such as septal perforation and mitral apparatus injury. sud-
denly were treated surgicall y (49) . Event s moved rapidly.
Some patient s with acute myocard ial infarction were taken
directly to the catheterization laboratory. On occasion. med-
ical revascularization was attempted with thrombol ytic en-
zymes (50, 5 1). Other pati ent s had emergency coronary ar-
teriography and , after definiti on of anatomy, surgical
revascularization (52) . Transluminal angioplasty . un-
dreamed of in 1958 , added a nonsurgical alternative to the
treatment of occlusive coronary disease (53) . Angiopl asty
evo lved so rapidly that present techn iques are probably tran-
sitional. During the 1970s, coronary arteriography and sur-
gical treatment of occlu sive coronary disease became com-
monpl ace , even before con sensus could be established for
indic ations and long-term effects.
Care of the Patient: 1983 Versus 1958
Office Diagnosis and Procedures
The magnitude of chan ge in the past quarter centu ry in
cardiology has been so great that a few pages can offer only
the barest outline. One way to view this change is to compare
the experience of the pat ient with heart disease in 1958 with
that of todays patient. The process in the physician ' s office
begins today much as it did then . The history. the physical
examination . the electrocardiogra m and the chest X-ray film
remain fundamental. There the similarity ends. For the pa-
tient with a heart murmur or an abnormal cardiac silhouette .
the echocardiogram and radionucl ide imaging and dynami c
studies provide information not imagined in 1958. Pericar-
dial effusion. mitral valve prolapse and stenosis. other val-
vular abnormalities. septal and free wall hypertrophy. car-
diac dilatation. ventricular dysfuncti on and a spectrum of
congenital anomalies may often be diag nosed noninvasively
in a matter of minute s in the ambulatory patient.
The limited surg ical alternatives in 1958 made acc urate
diagnosis much less urgent than today. Although some sur-
gical procedures were ava ilab le. the first prosthetic valve
had yet to be implanted (54) . Open heart surgery was limited
and not in general use because risks and results were pro-
hibiti ve . For the patient with otherwise nonremedial valvular
or myocardial disease. the option of cardiac transplantation
was in the realm of science fiction both techni cally and
immunologically . Tod ay. there are few valvular and con-
genital lesions for which some surgica l treatment is not
avai lable. Even cardi ac transplantation under certain cir-
cumstances is a practical option (55).
Coronary Heart Disea se
Angina pectoris. Although progress has been dramatic
in all phases of cardiovascular disease. it is the patient with
coronary heart disease who occ upies the center stage of
cardiology in 1983. Whether measured in terms of numbers.
procedures. results . doll ars or impact on medicine and so-
ciety. it is the diagnosis and treatment of coronary disease
that dom inates card iology . In 1958. the patient present ing
with chest pain and suspected of having ischemi c coro nary
disease required a relatively simple investigation. Thi s in-
clud ed a history. physical exa mination, resting electrocar-
diogram and perhaps a Master two-step test. Except for
nitroglycerin , therapy was not speci fic . The approach was
indirect and supportive and emphasized control of pain .
conges tive heart failure and arrhythmias. Related syndro mes
such as hypertension . hyperthyroidism , diabetes and obesity
were treated .
As is still the case, caveats included smoking. emotional
and physical stress and fatigue . In 1958 . there prob ably was
less emph asis on physical exerc ise and behavior modifica-
tion to control stress . Some controversies such as anticoag-
ulation and diet remain. A commentary on coronary artery
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disease (56). published in 1958, quoted an American Med-
ical Association Council on Food and Nutrition opinion.
" ... quite a bit more study concerning dietary fads will
have to be done before the average American eating habits
are to be drastically altered." The author also recommended
a low cholesterol diet despite the incomplete evidence. These
statements could have been written today.
With the exception of nitroglycerin. drug therapy for
symptomatic ischemic coronary disease is totally different
from that of 1958. The long dormant concept of coronary
artery spasm has been restored to clinical importance (57).
Long-acting nitrates, orally and transcutaneously, beta-re-
ceptor blocking drugs. calcium antagonists. more effective
diuretic drugs. peripheral vasodilators and psychoactive agents
contribute today to better control of angina.
Unstable angina. For the patient with chest pain hos-
pitalized in 1983 because of unstable angina. the experience
is entirely different from that of 1958. Today. he or she
will be placed in a cardiac care facility where electrocar-
diographic monitoring is constant and hemodynamic sur-
veillance available. The immediate therapeutic objective is
the control of symptoms and signs of clinical instability. In
addition to the pharmacologic regimen already described for
the ambulatory patient with angina. anticoagulant agents.
intravenous nitroglycerin and narcotic drugs may be used.
When the patient's condition has been controlled medically.
elective coronary arteriography and ventriculography will
be performed. A decision can then be made for definitive
medical or surgical management. If the patient's condition
cannot be stabilized medically. coronary arteriography will
be carried out as a relative emergency.
Acute myocardial infarction. For the patient with acute
myocardial infarction, the program is also dramatically dif-
ferent from that of 1958. The coronary care unit. with its
electrocardiographic and hemodynamic monitoring. capa-
bility for resuscitation, defibrillation. cardioversion and
transvenous pacing and intraaortic balloon assistance. was
unknown in 1958. In 1958 the hallmark of treatment for
acute myocardial infarction was protracted bed rest. perhaps
6 weeks. At that time. a radical innovation was to lift the
patient out of bed in a chair (58). While papers were be-
ginning to advocate a shorter stay for patients designated
as "mild," (59) it was not until the middle 1970s that bed
rest and length of stay were reduced materially (60).
Virtually every aspect of management of acute myo-
cardial infarction in /983 is different from that of /958.
One of the most important changes is philosophic. Today's
approach to the patient with acute myocardial infarction
looks beyond the acute phase. This attitude evolved after
the development of significant medical and surgical means
of improving long-term prognosis. From the moment the
patient enters the coronary care unit. prognostic evaluation
begins simultaneously with treatment. Clinical, electrocar-
diographic and hemodynamic evaluation helps to define short-
term prognosis. Relatively unfavorable factors include an-
terior location of infarction, cardiac enlargement. intra-
ventricular conduction defects, recurrent infarction. persis-
tent tachycardia. severe and protracted pain (61.62) and an
inordinately high rise in serum enzyme levels (63). From a
hemodynamic point of view, hypotension not due to hy-
povolemia, pulmonary congestion. elevated left ventricular
filling pressure or reduced ejection fraction suggests a more
ominous short-term prognosis (64). Recognition of right
ventricular infarction and the requirement for specific ther-
apy are new since 1958 (65). The severity of the myocardial
insult may be defined further by echocardiography (66) and
by radionuclide techniques (67). Other ways of categorizing
the acute infarction include the designations complete or
incomplete. transmural or nontransmural and complicated
or uncomplicated (60). Each of these categories is significant
in defining treatment and prognosis. For example, in 1958
a nontransmural infarction was considered relatively benign.
Today it is known that the future of patients with this con-
dition may be even more uncertain than that of patients with
a completed transmural lesion (68). The patient with un-
complicated myocardial infarction may be hospitalized for
less than 2 weeks and the patient with complicated infarction
rarely for more than 3.
Postinfarction management. After myocardial infarc-
tion, the ultimate prognosis depends on three factors-elec-
trical stability. the integrity of the myocardium and the
character of coronary artery stenosis. Long-term evaluation
begins before discharge from the hospital. It is at this point
that the decision-making process for patients with unstable
angina and patients with a recent myocardial infarction con-
verges. Here controversy remains. How important is the
presence of symptoms in patients who have had unstable
angina or recent myocardial infarction? What happens to
the patient depends on the philosophy of his or her phy-
sician and how the physician interprets the published data
and his or her own experience. Some physicians may select
a high risk postmyocardial infarction group by the response
to an exercise stress test (69). A 24 hour ambulatory
electrocardiogram may suggest a high risk category because
of electrical stability or an ischemic response to activity
(0). Other physicians may consider that all patients without
specific contraindications should have coronary anteriog-
raphy after recovery from acute myocardial infarction 01. 72).
Still others may proceed with a medical regimen without
even considering coronary arteriography.
Surgical therapy. One of cardiology's great dilemmas
today is in the surgical management of coronary disease.
Absolutes are few. Consensus currently favors surgical re-
vascularization for patients with obstructive left main dis-
ease or symptomatic multivessel occlusive coronary disease.
For patients with limited symptoms and less compelling
combinations of obstructive disease and left ventricular dys-
function there is no consensus. The selection of a medical
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regimen from available medications, exercise rehabilitation
(73) and behavior modification programs is no less perplexing.
Cardiology: Present Status
Thi s first issue of the Journal of the American College of
Cardi ology reviews and interprets the evolution of cardiol-
ogy during the past 25 years. Topics vary from epidemiology
to echocardiography. from enzymes to electrophysiology.
from revascularization to rehabilitation and from arrhyth-
mias to arteriography. Almo st everything written is new
since 1958. These advances are not confined to the great
centers. Relatively remote hospitals throughout the country
are staffed with highly trained cardiologists and offer so-
phisticated facilities.
Although it may seem that progress has made the work
of the physician easier now than in 1958. this impression
is misleading. Today. diagnosi s is more accurate and in-
tervention more decisive . The physician's responsibility is
much greater. Failure to diagnose bacteri al endocarditis , a
dissect ing aneurysm or an ulcerated carotid lesion. or to
recognize a subtle anginal equivalent . may deny the patient
a chance for a cure . As never before . the physician has the
opportunity to do good and the possibility to do harm.
Decision-making process. In every stage of the diag-
nostic and therapeutic process, the cardiologist will make
decision s and perform or advise procedures that will affect
the quality of life and perhaps even patient survival. The
deci sion-making process is the very essence of the practice
of medicine . Thi s is especially true for the cardiology of
1983.
In the practice of cardiology , the sett ing for a vital de-
cision is not necessarily dramatic . It is more likely to be
mundane and innocent. A 45 year old woman presents for
physical examination. She may describe a typical chest
pain . Her physician elects to perform a multilevel treadmill
stress test. ST-T segment depression occurs . A pivotal de-
cision must be made. Is the result of the exercise test de-
finitive ? Does it really suggest the probability of life-threat-
ening occlusive coronary disease ? Does it warrant
arteriography? Is it a false positive result or a normal vari-
ation ? Does it reall y correlate with the patient's history.
symptoms and other finding s? The phy sician ' s deci sion may
subject the patient to an expensive invasive procedure with
potential , though limited, risk of a major complication or
even death. Failure to perform the test may cause the di-
agnosis of life-threatening coronary disease to be missed .
A negati ve result may reas sure the patient, but at a cost
difficult to bear and which society is increasingl y reluctant
to absorb . This is true particularly if astute judgment could
avoid the procedure. The arteriogram may show some de-
gree of arterial narrowing. Again . a fateful decision must
be made . One judgment may lead the patient to the expense.
morbidity and danger of surgery. Another may choose a
medic al program. The decision for medical treatment when
surgery is needed is no less inappropriate than unnece ssary
surgery . The practice of medicine and cardiology is both
art and science: neither is exac t. Effective decision makin g
is as important to the patient and soc iety as the development
of the test and the procedure . The ingenuity . talent and
energy that created coronary arteriography and open heart
surgery are wasted if these procedures are applied inappro-
priately . The quality of the decision-making proce ss must
be comparable to that of the intervention it select s .
Evaluation of clinical trials . Since World War II. clin-
ical studies have become standard for evaluating diagnostic
and therapeutic procedures. Prospect ive, randomized. dou-
ble-blind trials have been used to document drug safety and
efficacy. However well intentioned. these studies are rarely
perfect. Although it is attractive to think that a protocol can
be designed to prove whether a drug or a procedure is
effective , in practice , unequivocal answer s are rare. Several
searching commentaries on therapeutic trials have described
their limitations (74-76) . Stati stical analysis may suggest a
good result erroneously or may not recognize a favorable
trend . The reasons for these errors are complex . The y may
be inherent in the design of the trial. in the execution or in
the interpretation. There are many instances in cardiology
where clin ical trial s are not definitive . Well known examples
are the use of anticoagulant and antiplatelet agent s . Iipid-
lowering diet s and agent s and . indeed. the role of myocardial
revascularization . The evaluation of a diagno stic or surgical
technique may be more difficult than that of a medication .
The composition of a medication is constant. The result of
a surgical procedure varies with the operator's skill.
Measures to improve decision-making process.
Because definitive answers are few. how can the decision-
making process be improved? Perhaps the first step is to
recognize that few tests provide absolute answers. The elec-
trocardiographic evolution of acute myocardial infarction,
an elevated blood sugar level or a positive pathologic biopsy
may be unequivocal. Many clinical tests on which decisions
are made are not. The significance of an exercise stress test ,
a coronary arteriogram or radionuclide imaging may be un-
certain . The significance of a test must be evaluated in the
clini cal context. The incidence of the disease in the popu-
lation which the patient repre sent s. the medications. phys-
ical finding s and symptoms are vitally important in inter-
pretation of a test. The phy sician must con sider sensitivity.
specificity and the positive and negative predictive value of
each test. The se usuall y cann ot be expressed in finite num-
bers. Becau se deci sion makin g is generally not based on
absolutes. the physician must have special qualities . These
are knowledge , experience, empathy, judgment and char-
acter. They are vital to the dec ision-making process. With-
out knowledge and experience . the physician lacks the in-
tellectual and practical balance to decide . Without empathy
he will not understand the patient' s symptoms. expectations
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and life situation requirements. Judgment and character are
the priceless ingredients. Unfortunately, some elements of
judgment are inherent, difficult to learn and not distributed
equally . Given a reasonable level of knowledge, experience,
empathy and judgment, it is character or integrity that may
be the most important intangible in the decision-making
process. This quality is demanded of the physician to whom
society has given the privilege of making vital decisions in
a milieu where he or she may be in conflict of interest. A
physician making decisions in cardiology in 1983 must put
aside self-interest and at times academic curiosity and the
desire of the virtuoso to perform in order to serve the best
interest of his patient.
As custodians of cardiology's historic advances, the car-
diologist and the cardiovascular surgeon are cast in a role
of problem solving and not case finding. The patient with
chest pain does not present to have a stress test or an ar-
teriogram or open heart surgery . He or she presents to have
a problem solved that may threaten a livelihood or a life .
He or she has the right to expect that in dealing with this
problem, the physician will draw appropriately from car-
diology's vast diagnostic and therapeutic reservoir. The phy-
sician who does less is an unworthy heir to cardiology 's
great legacy of 1983.
I express appreciation to Sylvia Stevens, Cardiology Coordinator , Good
Samaritan Hospital & Health Center, for invaluable assistance in the prep-
aration of this manuscript.
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